It looks like whomever was selling has stopped or paused. And the market thinks 15.5c is expensive.
Anything could happen from here. Literally.
Has the P2 for the FDA GVHD trial started yet? If not, why not?
You tell the market that preparation to start is done (ages ago), then you tell the market that (whoopsies), we forgot we needed money and that the need for money took everyone 'by surprise'. Then you do a CR and get the money to start. Isn't there a responsibility to inform the market when the trial will start?
Am I being too demanding? If I was a shareholder, I would want to know.
Has anyone asked them?
If they aren't doing this then what are they doing? Really, what else is there for them to do?
CYP Price at posting:
14.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)